1. Home
  2. ELDN vs ARL Comparison

ELDN vs ARL Comparison

Compare ELDN & ARL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eledon Pharmaceuticals Inc.

ELDN

Eledon Pharmaceuticals Inc.

HOLD

Current Price

$3.54

Market Cap

291.8M

Sector

Health Care

ML Signal

HOLD

Logo American Realty Investors Inc.

ARL

American Realty Investors Inc.

HOLD

Current Price

$15.00

Market Cap

261.7M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELDN
ARL
Founded
2004
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building operators
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
291.8M
261.7M
IPO Year
2014
1999

Fundamental Metrics

Financial Performance
Metric
ELDN
ARL
Price
$3.54
$15.00
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$8.50
N/A
AVG Volume (30 Days)
910.2K
10.9K
Earning Date
05-12-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
30.67
206.59
EPS
N/A
N/A
Revenue
N/A
$50,014,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
5.70
52 Week Low
$1.35
$12.42
52 Week High
$4.60
$24.44

Technical Indicators

Market Signals
Indicator
ELDN
ARL
Relative Strength Index (RSI) 45.41 43.89
Support Level $3.31 $15.17
Resistance Level $4.17 $15.83
Average True Range (ATR) 0.18 0.61
MACD 0.02 0.05
Stochastic Oscillator 46.40 44.70

Price Performance

Historical Comparison
ELDN
ARL

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.

About ARL American Realty Investors Inc.

American Realty Investors Inc is a fully integrated externally managed real estate company. The company operates high-quality multifamily and commercial properties throughout the Southern United States and also invests in mortgage notes receivable and in land that is either held for appreciation or development. It operates in two reportable segments: the acquisition, development, ownership and management of multifamily properties (Residential Segment) and the acquisition, ownership and management of commercial real estate properties (Commercial Segment). Maximum revenue is generated from its Residential segment, which includes the rental of apartments and other tenants.

Share on Social Networks: